课题基金 / 基金详情

I-Corps: Highly efficient/low cost method for mass production of graphene platelets

I-Corps: Highly efficient/low cost method for mass production of graphene platelets
I-Corps:大规模生产石墨烯片的高效/低成本方法
批准号:
1242993
负责人:
Michael Keidar
金额:
$5.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2012-12-31

项目摘要

项目成果

Michael Keidar的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This project will evaluate commercial potential of the novel approach of plasma-based method of graphene. The technical part of the project will be focused on creation of an industrial-scale prototype system for graphene synthesis. The proposed interdisciplinary project has both fundamental and technological significance. The fundamental significance is that our understanding of the fundamental role of plasmas in graphene synthesis will be greatly expanded. The technological and scientific significance lies in exploring the possibility of using various means to control graphene synthesis in arc discharge, possibility to enhance graphene production yield and ultimately pave the way for graphene mass production and industrial applications. Many important sectors of the national economy will be potentially affected. Successful development of the technology for producing graphene in a scalable manner (to produce large volumes of such) would have an enormous impact on energy storage, electronics, aerospace, mechanical, civil, and biomedical applications.This project has potential for a variety of industries. Since graphene was first created in the lab in 2004, graphene has been considered a material with significant promise. The two dimensional sheets of carbon atoms are the strongest material known, and graphene's electrical properties make it a potential replacement for silicon in faster computer chips. Together with industrial partners, the team is developing graphene-based electrochemical energy storage applications. They will evaluate the commercial potential of the material and will optimize its performance based on specific requirements from potential customers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RAPID: Cold Adaptive Atmospheric Plasma Decontamination of COVID-19
  • 批准号:
    2027876
  • 项目类别:
    Standard Grant
  • 资助金额:
    $20.0万
  • 财政年份:
    2020
  • 负责人:
    Michael Keidar
  • 依托单位:
PFI-TT: Cold plasma technology to enable a future cancer treatment device to reduce surgical margins
  • 批准号:
    1919019
  • 项目类别:
    Standard Grant
  • 资助金额:
    $25.0万
  • 财政年份:
    2019
  • 负责人:
    Michael Keidar
  • 依托单位:
IUCRC Phase I GWU: Center for High Pressure Plasma Energy, Agriculture, and Biomedical Technologies (PEAB)
  • 批准号:
    1747760
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $75.0万
  • 财政年份:
    2018
  • 负责人:
    Michael Keidar
  • 依托单位:
I-Corps: Cold Plasma Cancer Therapy
  • 批准号:
    1637906
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2016
  • 负责人:
    Michael Keidar
  • 依托单位:
海外基金